{"id":"https://openalex.org/W2002149980","doi":"https://doi.org/10.1089/cap.2011.0081","title":"Aripiprazole in Children with Tourette's Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study","display_name":"Aripiprazole in Children with Tourette's Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study","publication_year":2012,"publication_date":"2012-02-29","ids":{"openalex":"https://openalex.org/W2002149980","doi":"https://doi.org/10.1089/cap.2011.0081","mag":"2002149980","pmid":"https://pubmed.ncbi.nlm.nih.gov/22375853"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2011.0081","doi":"https://doi.org/10.1089/cap.2011.0081","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2011.0081","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051190122","display_name":"Gabriele Masi","orcid":"https://orcid.org/0000-0001-7770-926X","observed_orcids":["https://orcid.org/0000-0001-7770-926X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gabriele Masi","raw_affiliation_strings":["IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy","IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy. gabriele.masi@inpe.unipi.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy","institution_ids":[]},{"raw_affiliation_string":"IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy. gabriele.masi@inpe.unipi.it","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088272847","display_name":"Antonella Gagliano","orcid":"https://orcid.org/0000-0001-9367-7739","observed_orcids":["https://orcid.org/0000-0001-9367-7739"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonella Gagliano","raw_affiliation_strings":["Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027142152","display_name":"Rosamaria Siracusano","orcid":"https://orcid.org/0000-0003-3552-9070","observed_orcids":["https://orcid.org/0000-0003-3552-9070"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rosamaria Siracusano","raw_affiliation_strings":["Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026826311","display_name":"Stefano Berloffa","orcid":"https://orcid.org/0000-0002-7139-5420","observed_orcids":["https://orcid.org/0000-0002-7139-5420"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefano Berloffa","raw_affiliation_strings":["IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089522739","display_name":"Tiziana Calarese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Tiziana Calarese","raw_affiliation_strings":["Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090222575","display_name":"Giovanna Ilardo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanna Ilardo","raw_affiliation_strings":["Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Child Neurology and Psychiatry, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026077616","display_name":"Chiara Pfanner","orcid":"https://orcid.org/0000-0002-6970-3578","observed_orcids":["https://orcid.org/0000-0002-6970-3578"]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Pfanner","raw_affiliation_strings":["IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy","Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy","institution_ids":[]},{"raw_affiliation_string":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","institution_ids":["https://openalex.org/I4210091493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059975802","display_name":"Angela Magaz\u00f9","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Magaz\u00f9","raw_affiliation_strings":["IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRCCS Stella Maris, Scientific Institute Child Neurology and Psychiatry, Calambrone, Pisa, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086816670","display_name":"Clemente Cedro","orcid":"https://orcid.org/0000-0003-1311-3787","observed_orcids":["https://orcid.org/0000-0003-1311-3787"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Clemente Cedro","raw_affiliation_strings":["Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, University of Messina, Messina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosciences, Psychiatric and Anaesthesiological Sciences, University of Messina, Messina, Italy","institution_ids":["https://openalex.org/I112862951"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5051190122"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7141,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.93751511,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"22","issue":"2","first_page":"120","last_page":"125"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9909999966621399},{"id":"https://openalex.org/keywords/tourette-syndrome","display_name":"Tourette syndrome","score":0.9919999837875366},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9739999771118164},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7789999842643738},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.6800000071525574},{"id":"https://openalex.org/keywords/tic-severity","display_name":"tic severity","score":0.5839999914169312},{"id":"https://openalex.org/keywords/adhd-symptoms","display_name":"ADHD symptoms","score":0.5009999871253967},{"id":"https://openalex.org/keywords/dopamine-partial-agonists","display_name":"partial dopamine agonist","score":0.847000002861023},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.6850000023841858},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder-comorbidity","display_name":"obsessive-compulsive disorder comorbidity","score":0.8759999871253967},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.5270000100135803},{"id":"https://openalex.org/keywords/yale-global-tic-severity-scale","display_name":"Yale Global Tic Severity Scale","score":0.7639999985694885},{"id":"https://openalex.org/keywords/adhd-rs-iv","display_name":"ADHD-RS-IV","score":0.8889999985694885},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.9065138101577759},{"id":"https://openalex.org/C2777200579","wikidata":"https://www.wikidata.org/wiki/Q738538","display_name":"Tics","level":2,"score":0.880508542060852},{"id":"https://openalex.org/C2777026814","wikidata":"https://www.wikidata.org/wiki/Q191779","display_name":"Tourette syndrome","level":2,"score":0.7319695949554443},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6701167821884155},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6349978446960449},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.482570081949234},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4232722520828247},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3996054530143738},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32003486156463623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28028786182403564},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.156767338514328},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.14953401684761047},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08595314621925354}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005879","descriptor_name":"Tourette Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D005879","descriptor_name":"Tourette Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005879","descriptor_name":"Tourette Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/cap.2011.0081","doi":"https://doi.org/10.1089/cap.2011.0081","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2011.0081","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:22375853","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22375853","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:iris.unica.it:11584/279475","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11584/279475","pdf_url":null,"source":{"id":"https://openalex.org/S4377196293","display_name":"UNICA IRIS Institutional Research Information System (University of Cagliari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I172446870","host_organization_name":"University of Cagliari","host_organization_lineage":["https://openalex.org/I172446870"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W1965070231","https://openalex.org/W1969747415","https://openalex.org/W1971179661","https://openalex.org/W1979497620","https://openalex.org/W1982573127","https://openalex.org/W1983302342","https://openalex.org/W1984204990","https://openalex.org/W1989893437","https://openalex.org/W1992117212","https://openalex.org/W1995484354","https://openalex.org/W1999019624","https://openalex.org/W1999789853","https://openalex.org/W2001006163","https://openalex.org/W2014699813","https://openalex.org/W2015687720","https://openalex.org/W2019101336","https://openalex.org/W2020414031","https://openalex.org/W2021844653","https://openalex.org/W2022353753","https://openalex.org/W2034869390","https://openalex.org/W2038759008","https://openalex.org/W2040996693","https://openalex.org/W2041038426","https://openalex.org/W2047946090","https://openalex.org/W2067961491","https://openalex.org/W2068402544","https://openalex.org/W2071472682","https://openalex.org/W2071897904","https://openalex.org/W2074315389","https://openalex.org/W2079637753","https://openalex.org/W2087040765","https://openalex.org/W2101821137","https://openalex.org/W2114776324","https://openalex.org/W2121769610","https://openalex.org/W2123724553","https://openalex.org/W2126094233","https://openalex.org/W2128738187","https://openalex.org/W2164549762","https://openalex.org/W2167062019","https://openalex.org/W2195123592","https://openalex.org/W2266471137","https://openalex.org/W2287028165","https://openalex.org/W2502993979","https://openalex.org/W3196369884"],"related_works":["https://openalex.org/W2022353753","https://openalex.org/W2942726252","https://openalex.org/W2079637753","https://openalex.org/W2020414031","https://openalex.org/W1877148138","https://openalex.org/W2726321932","https://openalex.org/W2411593212","https://openalex.org/W2291398686","https://openalex.org/W4404858903","https://openalex.org/W2033561156"],"abstract_inverted_index":{"Tourette's":[0],"disorder":[1,12,246],"(TD)":[2],"in":[3,30,67,89,164,169,180,235,243,268],"children":[4],"and":[5,70,102,114,125,140,177,253,303],"adolescents":[6],"is":[7],"frequently":[8],"co-morbid":[9,52,103,247],"with":[10,96],"attention-deficit/hyperactivity":[11],"(ADHD).":[13],"Dopamine-blockers":[14],"are":[15,27],"the":[16,28,31,41,81,115,131,152,156,174,194,202,244,256],"first":[17],"line":[18],"treatment":[19,32,153,271],"for":[20,45,173,272],"TD,":[21,273],"whereas":[22],"dopamine-agonists,":[23],"such":[24],"as":[25,60,121],"stimulants,":[26],"gold-standard":[29],"of":[33,83,93,100,135,141,162,167,178,189,193,213,231,255,261],"ADHD.":[34,304],"These":[35],"contrasting":[36],"effects":[37],"supported":[38],"concerns":[39],"about":[40],"risk":[42],"that":[43,288],"stimulants":[44],"treating":[46],"ADHD":[47,282],"may":[48,290],"trigger":[49],"or":[50],"worsen":[51],"tics.":[53],"Aripiprazole,":[54],"a":[55,90,97,160,187,225,229,292],"partial":[56],"dopamine":[57,64],"agonist,":[58],"acts":[59],"an":[61,211,219,269],"antagonist":[62],"at":[63,190,201,232],"D2":[65],"receptors":[66],"hyperdopaminergic":[68],"conditions":[69],"displays":[71],"agonist":[72],"properties":[73],"under":[74],"hypodopaminergic":[75],"conditions.":[76],"The":[77,107,199],"present":[78],"study":[79],"describes":[80],"use":[82],"aripiprazole":[84,266,289],"(10.0":[85],"\u00b1":[86],"4.8":[87],"mg/day)":[88],"consecutive":[91],"group":[92],"28":[94],"patients":[95,184,208,257],"primary":[98,122],"diagnosis":[99],"TD":[101],"ADHD,":[104],"combined":[105,175],"subtype.":[106],"Yale":[108],"Global":[109,133,138,145],"Tic":[110],"Severity":[111],"Scale":[112,117],"(YGTSS)":[113],"ADHD-Rating":[116],"(ADHD-RS-IV)":[118],"were":[119],"used":[120],"outcome":[123],"measures":[124,134],"both":[126,301],"significantly":[127,149],"improved":[128,150],"(p<0.001)":[129],"after":[130],"treatment.":[132],"severity":[136],"(Clinical":[137],"Impressions-Severity)":[139],"functional":[142],"impairment":[143],"(Children's":[144],"Assessment":[146],"Scale)":[147],"also":[148],"during":[151],"(p<0.001).":[154],"At":[155],"YGTSS":[157,195],"there":[158],"was":[159,205,238,250,276],"reduction":[161,188,230],"42.5%,":[163],"motor":[165],"tics,":[166],"47.9%":[168],"phonic":[170],"tics":[171,302],"(44.7%":[172],"scores),":[176],"32.3%":[179],"tic":[181],"impairment.":[182],"Nineteen":[183],"(67.9%)":[185],"had":[186],"least":[191,233],"50%":[192],"score":[196,204,237],"(motor+phonic":[197],"tics).":[198],"improvement":[200,212,220],"ADHD-RS-IV":[203,236],"22.5%,":[206],"12":[207],"(42.8%)":[209],"presented":[210],"30%,":[214],"but":[215,274],"only":[216,277],"2":[217],"(7.1%)":[218],"greater":[221],"than":[222],"50%.":[223],"Using":[224],"logistic":[226],"regression":[227],"model,":[228],"30%":[234],"more":[239],"likely":[240],"to":[241],"occur":[242],"obsessive-compulsive":[245],"group.":[248],"Aripiprazole":[249],"well":[251],"tolerated":[252],"none":[254],"discontinued":[258],"medication":[259],"because":[260],"side":[262],"effects.":[263],"In":[264],"summary,":[265],"resulted":[267],"effective":[270,279],"it":[275],"moderately":[278],"on":[280],"co-occurring":[281],"symptomatology.":[283],"Our":[284],"preliminary":[285],"data":[286],"suggest":[287],"represent":[291],"possible":[293,298],"therapeutic":[294],"option,":[295],"among":[296],"other":[297],"monotherapies":[299],"addressing":[300]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}